CLOS
LONA

Compagnie Lombard Odier SCmA’s LeonaBio Inc LONA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-260
Closed -$34K – 602
2021
Q4 		$34K Buy
+260
New +$32.9K ﹤0.01% 537

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Compagnie Lombard Odier SCmA's LONA Position: Q1 2022 in Review

Compagnie Lombard Odier SCmA sold out of LeonaBio Inc (LONA) in Q1 2022, closing a stake of 260 shares — an estimated $34K sold.

Compagnie Lombard Odier SCmA first reported a position in LONA in Q4 2021 and held it in 1 quarter. The position peaked at $34K in Q4 2021. 105 funds tracked by Wall St. Rank hold LONA as of Q1 2022.

  • Compagnie Lombard Odier SCmA reported no remaining LeonaBio Inc position as of Q1 2022 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 260 LeonaBio Inc shares in Q1 2022, an estimated $34K.
  • Compagnie Lombard Odier SCmA first reported a position in LeonaBio Inc in Q4 2021 and held it in 1 quarter.
  • Compagnie Lombard Odier SCmA's LeonaBio Inc position peaked at $34K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2022.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2022, filed 27 Apr 2022.